About Cardiac Rhythm Management Devices
Cardiac rhythm management or electrophysiology therapy helps diagnose and treat heart disorders that cause rhythm complications. These disorders include bradycardia and tachycardia that affect the heart's electrical system. These disorders cause irritation in the heart muscles, causing abnormal heart functions. This can occur during heart attacks. Devices such as ICDs, CRT systems, and biventricular pacemakers help manage these disorders.
Technavio’s analysts forecast the cardiac rhythm management devices market in China to grow at a CAGR of 10.1% during the period 2016-2020.
Covered in this report
The report covers the present scenario and the growth prospects of the cardiac rhythm management devices market in China 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of pacemakers, ICTs, and CRT devices.
Technavio's report, Cardiac Rhythm Management Devices Market in China 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the operating in this market.
Key vendors
• BIOTRONIK
• Boston Scientific
• LivaNova
• Medtronic
Other prominent vendors
• Anjue Medical Equipment
• Beijing Carejoy Technology
• CardiAid
• E&M Electromedicina
• EMTEL
• Fukuda Denshi
• Guangzhou Leyte Electronic
• Guangzhou Maya Medical Equipment
• Guangzhou Yueshan Medical Equipment
• Hagenuk
• Instramed
• Lepu Medical Technology (Beijing)
• Mindray Medical International
• Perlong Medical Equipment
• Physio Control
• Poweam Medical
• Wincom
Market driver
• Prevalence of cardiac disorders
• For a full, detailed list, view our report
Market challenge
• Promotion of locally manufactured products
• For a full, detailed list, view our report
Market trend
• Popularity of robot-assisted cardiac surgery
• For a full, detailed list, view our report
Key questions answered in this report
• What will the market size be in 2020 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?
You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.
PART 01: Executive summary
• Highlights
PART 02: Scope of the report
• Market overview
• Top-vendor offerings
PART 03: Market research methodology
• Research methodology
• Economic indicators
PART 04: Introduction
• Key market highlights
PART 05: Healthcare reform in China
• Healthcare reforms
• Improvement in healthcare infrastructure
PART 06: Regulatory landscape
PART 07: Insurance coverage and reimbursement in China
• Insurance
• Reimbursement
PART 08: Opportunities for global and local vendors
• Local vendors
• Global vendors
• Challenges for global vendors
PART 09: Market landscape
• Market overview
• Market size and forecast
• Five forces analysis
PART 10: Market segmentation by product
• Pacemakers
• ICDs
• CRT devices
PART 11: Market drivers
• Prevalence of cardiac disorders
• Expansion of insurance plans
• Increase in joint ventures
• Advances in surgical procedures
PART 12: Impact of drivers
PART 13: Market challenges
• Complications of CRT in children
• Preference for open surgeries
• Promotion of locally manufactured products
• Stringent regulatory framework
PART 14: Impact of drivers and challenges
PART 15: Market trends
• Popularity of robot-assisted cardiac surgery
• Use of MRI in clinical applications
PART 16: Vendor landscape
• Competitive scenario
• Key vendors
• BIOTRONIK (Beijing) Medical Devices
• BSC Medical Device Technology (Shanghai)
• Cardiac Science
• Koninklijke Philips
• LivaNova
• Medtronic
• St. Jude Medical
• Other prominent vendors
PART 17: Appendix
• List of abbreviations
PART 18: Explore Technavio
List of Exhibits
Exhibit 01: Product offerings
Exhibit 02: Limitations of cardiac rhythm management devices
Exhibit 03: Disease mortality rate in China 2012
Exhibit 04: Healthcare reforms in China
Exhibit 05: Healthcare spending in China 2005-2014
Exhibit 06: Segmentation of hospitals in China 2014
Exhibit 07: Segmentation of hospitals in China by Tier 2014
Exhibit 08: Approval timeline for medical devices in China compared to other countries
Exhibit 09: Health insurance system in China
Exhibit 10: Various establishments of global medical device manufacturers in China
Exhibit 11: Cardiac rhythm management devices market in China 2015-2020 ($ millions)
Exhibit 12: Five forces analysis
Exhibit 13: Segmentation of cardiac rhythm management devices market in China by product
Exhibit 14: Segmentation of cardiac rhythm management devices market in China by product 2015
Exhibit 15: Segmentation of cardiac rhythm management devices market in China by product 2020
Exhibit 16: Segmentation of cardiac rhythm management devices market by product 2015-2020
Exhibit 17: Pacemakers based on functionality
Exhibit 18: Some indications for insertion of implanted pacemaker
Exhibit 19: Cardiac rhythm management devices market in China for pacemakers 2015-2020 ($ millions)
Exhibit 20: Some indications for ICDs
Exhibit 21: Cardiac rhythm management devices market in China for ICDs 2015-2020 ($ millions)
Exhibit 22: Types of CRT devices
Exhibit 23: Cardiac rhythm management devices market in China for CRT devices 2015-2020 ($ millions)
Exhibit 24: Impact of drivers
Exhibit 25: Impact of drivers and challenges
Exhibit 26: Product portfolio matrix
Exhibit 27: BIOTRONIK: Key takeaways
Exhibit 28: BSC Medical Device Technology (Shanghai): Key takeaways
Exhibit 29: Cardiac Science: Key takeaways
Exhibit 30: Koninklijke Philips: Key takeaways
Exhibit 31: LivaNova: Key takeaways
Exhibit 32: Medtronic: Key takeaways
Exhibit 33: St. Jude Medical: Key takeaways
